Epilepsy, Partial Clinical Trial
Official title:
A Double-Blind, Randomized, Multicenter, Placebo-controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/Day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age From 1 Month to Less Than 4 Years of Age
To evaluate the safety and efficacy of levetiracetam used as adjunctive treatment in pediatric subjects age 1 month to less than 4 years with partial onset seizures. Subjects will be evaluated with 48 hour inpatient video electroencephalograms (a selection and an evaluation). Other neuropsychological clinical assessments will be performed during the 34 day length of the study.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00105040 -
A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures
|
Phase 2 | |
| Completed |
NCT00160615 -
Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method
|
Phase 3 | |
| Completed |
NCT00113165 -
Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
|
Phase 3 | |
| Completed |
NCT00152516 -
Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures
|
Phase 3 | |
| Withdrawn |
NCT01691872 -
Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects
|
Phase 1 | |
| Completed |
NCT00160654 -
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
|
Phase 4 | |
| Terminated |
NCT01545518 -
IVIG Treatment for Refractory Immune-Related Adult Epilepsy
|
Phase 2 | |
| Completed |
NCT00141414 -
To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.
|
Phase 2 | |
| Completed |
NCT01332539 -
An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy
|
N/A | |
| Completed |
NCT00355082 -
Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
|
Phase 3 | |
| Completed |
NCT00152451 -
Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures
|
Phase 2 | |
| Withdrawn |
NCT02220972 -
To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures
|
Phase 4 | |
| Completed |
NCT00160628 -
Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy
|
Phase 3 | |
| Completed |
NCT00245713 -
Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.
|
Phase 4 | |
| Terminated |
NCT01375374 -
Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide
|
Phase 3 | |
| Completed |
NCT00152373 -
Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS
|
Phase 3 | |
| Completed |
NCT00150709 -
A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy
|
Phase 3 | |
| Completed |
NCT00643500 -
Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
|
Phase 4 | |
| Completed |
NCT00152503 -
Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam
|
Phase 2 | |
| Terminated |
NCT01891890 -
Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)
|
Phase 3 |